S9 Ep28: FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma

OncLive® On Air - Un pódcast de OncLive® On Air

prueba podimo gratis durante 60 días!

prueba podimo gratis durante 60 días!

Miles de audiolibros y podcasts exclusivos, haz clic aquí para probar
Podcast artwork

Dr Nooka discusses the FDA approval of elranatamab in relapsed/refractory multiple myeloma, key data from MagnetisMM-3, and the evolving role of bispecific antibodies in the multiple myeloma treatment paradigm.

Visit the podcast's native language site